Is Geraniol safe in cosmetics?
Geraniol has a safety rating of "MODERATE" in our database. EU status: restricted. US status: permitted. 3 toxicological study endpoint(s) are available in our database.
INCI: GERANIOL
Geraniol (CAS 106-24-1) is a cosmetic fragrance functioning as fragrance; antimicrobial. NOAEL 300 mg/kg bw/day (cross-referenced against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: restricted, max 10 ppm in leave-on products, 100 ppm in rinse-off products. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in pharmaceutical data.
View industrial chemical safety profile for CAS 106-24-1 →
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Geraniol.
Calculate MoS for your specific formulation with the MoS Calculator.
3 study endpoints found for Geraniol. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | 50 mg/kg bw/day | oral | rat | Subchronic | COSMOS_DB |
| NOAEL | 500 mg/kg bw/day | oral | rat | Subchronic | COSMOS_DB |
| NOAEL | =300 mg/kg bw/day | dermal | Rat | developmental | ToxValDB_ECHA_IUCLID |
Pre-calculated NOAEL → SED → MoS audit trail for Geraniol across SCCS product categories, with measured dermal absorption where available.
Contact sensitization data for Geraniol based on clinical patch test studies and IFRA standards.
Source: ESSCA/IVDK
Skin absorption and penetration characteristics of Geraniol, relevant to systemic exposure and MoS calculations.
Source: SCCS/1459/11, IFRA
7 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
| Endpoint | Value | Species | Route | Duration | Source |
|---|---|---|---|---|---|
| NOAEL | =345 mg/kg-day | Rat | oral | chronic | EFSA |
| LD50 | =3600 mg/kg-day | Rat | oral | - | EFSA |
| NOAEL | =300 mg/kg-day | Rat | dermal | - | ECHA IUCLID |
| NOAEL | =300 mg/kg-day | Rat | dermal | - | ECHA IUCLID |
| NOAEL | =300 mg/kg-day | Rat | oral | - | ECHA IUCLID |
| LD50 | >5000 mg/kg | Rabbit | dermal | - | ChemIDplus |
| LD50 | =3600 mg/kg | Rat | oral | - | ChemIDplus |
Legally binding harmonized classification per Regulation (EC) No 1272/2008 (CLP) Annex VI.
Inserted via ATP: ATP15
Adverse Outcome Pathway data across 5 assays (DPRA, KeratinoSens, hCLAT, LLNA, NESIL) aggregated from public sources.
Source: LLNA: Lalko et al. (2004) (RIFM DB #37070) | Lalko et al. (2004)(RIFM DB #37071); DPRA: Natsch et al. 2013 [DOI:10.1002/jat.2868] | Nukada et al. 2013 [DOI:10.1016/j.tiv.2012.11.006]; KS: Urbisch et al. 2015 [DOI:10.1016/j.yrtph.2014.12.008] | Joint Research Centre of the European Union 2014; hCLAT: Ashikaga et al. 2010 [DOI:10.1177/026119291003800403] | Unilever commissioned, IIVS; HPPT: [184] Opdyke DLJ (1974): Geraniol. Personal communication, unpublished.
5 human repeat insult patch tests aggregated from dermatological literature.
| Test Type | N | Sensitized | Dose µg/cm² | NESIL µg/cm² | Potency |
|---|---|---|---|---|---|
| HRIPT | 112 | 0 | 11811 | 11811 | non-sensitizer |
| HRIPT | 109 | 0 | 5905 | 5905 | non-sensitizer |
| HRIPT | 110 | 0 | 2362 | 2362 | non-sensitizer |
| HRIPT | - | 0 | 11811 | 11811 | weak |
| HMT | - | 0 | 3240 | - | - |
Cross-referenced EDC classifications, mechanism data, and dose-response evidence from EDLists, SIN List, and cosmetic-specific detail sources.
modulator (thyroid)
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
| Jurisdiction | Status | Max % | Product Type |
|---|---|---|---|
| AU | restricted | 5.0 | fragrances |
| GCC | restricted | 0.001 | Leave-on products |
Cross-database dermal penetration: EPA Dryad physics-based, Roberts Mendeley permeation, and SCCS-aggregated measured values.
Source: EPA_Dryad_Skin_Absorption_2024
Source: Roberts_Cheruvu_Mendeley_2022
| Type | DA % | Method | Skin Model | SCCS Ref |
|---|---|---|---|---|
| measured_in_vitro | 3.5-7.3 | In vitro; flow-through diffusion cells; [14C]-labelled | Human cadaver skin; occluded | Gilpin et al. 2010 (Dermatitis) (2010) |
International Fragrance Association standards per product category. Restriction: Restriction. Effective: 2024-01-01.
| Category | Max % | Category | Max % |
|---|---|---|---|
| 1 (Lip products) | 0.5% | 7a (Deodorant – not spray) | 1.0% |
| 2 (Body spray) | 0.15% | 7b (Deodorant spray) | 1.0% |
| 3 (Body cream) | 0.5% | 8 (Face cream) | 0.17% |
| 4 (Fine fragrance) | 2.0% | 9 (Soap) | 2.5% |
| 5a (Body lotion) | 0.5% | 10a (Household – non-spray) | 2.5% |
| 5b (Face cream leave-on) | 0.5% | 10b (Household – spray) | No Restriction% |
| 5c (Hand cream) | 0.5% | 11a (Intimate – leave-on) | 0.17% |
| 5d (Baby cream) | 0.17% | 11b (Intimate – rinse) | 0.17% |
| 6 (Mouthwash) | 0.5% | 12 (Not for consumer exposure) | No Restriction% |
Reported concentration ranges per product category from SCCS/CIR/industry sources.
| Product Category | Typical Range | Max Reported | Source |
|---|---|---|---|
| Perfume | 0.01–1 | 5 | CIR/VCRP |
10 property records from structured ingredient metadata.
Expert safety assessment and concern-level summary for Geraniol.
Public NOAEL study rows linked to Geraniol by CAS number or substance name.
| Absorption % | Method | Vehicle |
|---|---|---|
| 3.5-7.3 | In vitro; flow-through diffusion cells; [14C]-labelled | 3:1 DEP/ethanol |
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Geraniol has a safety rating of "MODERATE" in our database. EU status: restricted. US status: permitted. 3 toxicological study endpoint(s) are available in our database.
Geraniol EU regulatory status: restricted. Maximum allowed concentration: 10 ppm in leave-on products, 100 ppm in rinse-off products. This is based on EU Regulation 1223/2009 and its amendments.
Geraniol functions as: fragrance; antimicrobial. It is classified as a Fragrance in our database. CAS number: 106-24-1.
The NOAEL (No Observed Adverse Effect Level) for Geraniol is 50 mg/kg bw/day based on a Subchronic study via oral route in rat. A total of 3 study endpoints are available. Source: COSMOS_DB.
Geraniol also appears in pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Check Geraniol compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Geraniol in your formulation.